News
Video News
Mining Videos
News
Coin
Video News
Mining Videos
Search
Japan's Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50%
1 week ago
Takeda Pharmaceutical (NYSE: TAK) reveals fiscal year 2023 results & restructuring plan. Revenue up 5.9%, net profit down 54.6%. Expecting operating …
Read Entire Article
Homepage
News
Japan's Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50%
Related
OKX Ventures Invests in Bitcoin Layer 2 Solution, Bitlayer
2 hours ago
FOMO HOUR 118 - ARE THE ETFS BACK? - Decrypt
2 hours ago
Composite Interest Rate Drops to 2.65% in April 2024, Announ...
2 hours ago
Power Plays: How Web3 Companies Leverage Tokens And NFTs For...
3 hours ago
Binance Research estimates token unlocks to reach $155 billi...
3 hours ago
Bitcoin Edges Past $67K as Analysts Predict It'll Keep Climb...
3 hours ago
Balaji Srinivasan Highlights China’s Dedollarization and Env...
3 hours ago
US Dollar May Depreciate 4%, MUFG’s Halpenny Says
3 hours ago
Popular
Standing by RogerVer and decentralized money
11 hours ago
Markets Update: Bitcoin Continues to Orbit Above $3K
20 hours ago
Spot Ethereum ETF 🚨 Crypto's Next Milestone? 🚀 (Full Analysi...
19 hours ago
YOU NEED TO SEE THIS! 🔥 FFIE AMC AND GAMESTOP STOCK PRICE PR...
17 hours ago
Yuval Harari Criticizes Bitcoin, Naira Becomes World’s Worst...
11 hours ago
Is government banning Bitcoin ownership? Cobra speaks out
11 hours ago